NCT06133803

Lovenox With Aspirin in Thawed Blastocyst Transfer

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 130 (estimated)
• Sponsor: Fertility Center of Las Vegas · Industry
• Sex: Female
• Age: 18 Years – 42 Years
• Healthy volunteers: Accepted

Summary

This prospective randomized trial will compare outcomes in patients receiving aspirin in combination with a low-molecular weight heparin and those under this center's standard protocol receiving neither medication, in order to determine if these medications may improve success rates.

Detailed description

This prospective randomized trial will compare outcomes in patients receiving aspirin (81mg daily) in combination with a low-molecular weight heparin (LMWH) (enoxaparin (Lovenox®), 40mg daily subcutaneous injection) and those under this center's standard protocol receiving neither medication, in order to determine if these medications may improve success rates.

Conditions

• Infertility, Female

Interventions

Type	Name	Description
DRUG	Lovenox	A low-molecular-weight heparin, 40mg daily injection.
DRUG	Aspirin	Aspirin 81mg daily tablet.
PROCEDURE	Embryo transfer	Embryo transfer

Timeline

• Start date: 2024-01-26
• Primary completion: 2024-12-15
• Completion: 2024-12-15
• First posted: 2023-11-18
• Last updated: 2024-02-21

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study